A carregar...
Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth
Glioblastoma is the most common and lethal brain tumor associated with only 12% median survival rate of patients. Despite the development of advanced surgical, radiation or use of combinations of anti-cancer drugs, treatment for glioblastoma patients is still a challenge. The major contributing fact...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564593/ https://ncbi.nlm.nih.gov/pubmed/28512255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17425 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|